Follow The Filings

SGMT position history

The shares of Sagimet Biosciences Inc-A (SGMT) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.

Equity, COM SER A

Shares held by quarter

New Add Reduce Exit

  1. 2026 Q2: 415,000 shares, $3.2M, 0.01% of portfolio, New
Holdings date Value % of holdings Shares Filing date All 13F holders